CD3/CD28 T cell proliferation assay

FG Fabiany da C. Gonçalves
FL Franka Luk
SK Sander S. Korevaar
RB Rachid Bouzid
AP Ana H. Paz
CL Carmen López-Iglesias
CB Carla C. Baan
AM Ana Merino
MH Martin J. Hoogduijn
request Request a Protocol
ask Ask a question
Favorite

To evaluate the immunomodulatory capacity of MP, PBMC were labeled with 1 μM of CFSE and plated in round bottom 96-well culture plates at a density of 5 × 104 cells/well. T cell proliferation was stimulated by adding human anti-CD3/anti-CD28 antibodies (1 µl/ml each) with a linker antibody Ig (2 µl/ml) (BD Biosciences). PBMC were incubated with different ratios of MP, or MPγ (1:5,000, 1:10,000, 1:40,000, 1:80,000) for 4 days. On the fourth day, non-adherent PBMC were removed from the plate, washed with FACS Flow and incubated with monoclonal antibodies against CD4-PerCP and CD8-PE-Cy7 (antibodies were purchased from BD Biosciences) at room temperature for 30 min. When a CFSE-labeled cell divides, its progeny are endowed with half the number of CFSE-tagged molecules and thus each cell division can be assessed by measuring the corresponding decrease in cell fluorescence by flow cytometry.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A